Literature DB >> 8101542

T cell receptor V alpha-V beta combinatorial selection in the expressed T cell repertoire.

M S Vacchio1, L Granger, O Kanagawa, B Malissen, K Tomonari, S O Sharrow, R J Hodes.   

Abstract

This study has evaluated whether preferential pairing occurs between TCR alpha- and beta-chains expressing specific V alpha and V beta gene products in the mature peripheral T cell population, as a result of either thymic selection or of structural constraints on chain pairing. The association of specific V alpha products with specific V beta products on individual T cells was found, in multiple instances, to be highly selective. Moreover, patterns of preferential V alpha-V beta association were highly strain-specific and were independently expressed in CD4+ and CD8+ T cell subsets. Although these findings do not exclude the possibility that structural constraints may limit V alpha-V beta pairing in other instances, they indicate that the observed instances of skewed expression are not caused by structural constraints in chain pairing. Rather, they suggest that strain-specific selective events alter the expressed V alpha V beta repertoire as a result of recognition of self or environmental Ag during T cell repertoire selection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101542

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

Review 1.  Molecular mimicry as a mechanism of autoimmune disease.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  The somatically generated portion of T cell receptor CDR3α contributes to the MHC allele specificity of the T cell receptor.

Authors:  Philippa Marrack; Sai Harsha Krovi; Daniel Silberman; Janice White; Eleanor Kushnir; Maki Nakayama; James Crooks; Thomas Danhorn; Sonia Leach; Randy Anselment; James Scott-Browne; Laurent Gapin; John Kappler
Journal:  Elife       Date:  2017-11-17       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.